Aura Biosciences, Inc. — Insider Transactions
Form 4 filings by directors, officers, and 10%+ shareholders
SEC rules require corporate insiders — including directors, executive officers, and any shareholder owning more than 10% of a company's shares — to report changes in their ownership within two business days of a transaction. These disclosures are filed as Form 4. Open-market purchases (code P) are generally considered the most meaningful signal, as insiders are spending their own money.
| Insider | Title | Type | Shares | Price | Value | Owns After | Date |
|---|---|---|---|---|---|---|---|
| Hopkins Janet Jill | Chief Medical Officer | Sale | 17,109 | $5.42 | $92,731 | 252,685 | Nov 17, 2025 |
| Elazzouzi Amy | Senior Vice President, Finance | Sale | 896 | $6.35 | $5,690 | 85,662 | Oct 29, 2025 |
| de los Pinos Elisabet | See Remarks | Sale | 9,049 | $6.35 | $57,461 | 474,391 | Oct 29, 2025 |
| Plavsic Mark | Chief Technology Officer | Sale | 12,169 | $6.35 | $77,273 | 197,287 | Oct 16, 2025 |
| Elazzouzi Amy | Senior Vice President, Finance | Option Exercise | 1,094 | $3.16 | $3,457 | 91,961 | Aug 18, 2025 |
| Srivastava Sapna | — | Award / Grant | 13,000 | — | — | 23,500 | Jun 17, 2025 |
| Johnson David Michael | — | Award / Grant | 13,000 | — | — | 179,167 | Jun 17, 2025 |
| Mattessich Antony C. | — | Award / Grant | 13,000 | — | — | 23,500 | Jun 17, 2025 |
| Gibney Anthony S | See Remarks | Award / Grant | 150,000 | — | — | 206,933 | Jun 2, 2025 |
| de los Pinos Elisabet | See Remarks | Tax Withholding | 9,948 | $6.16 | $61,280 | 483,440 | Jun 2, 2025 |
| Johnson David Michael | — | Purchase | 20,000 | $4.90 | $98,000 | 166,167 | May 16, 2025 |
| Gibney Anthony S | See Remarks | Sale | 1,519 | $5.15 | $7,823 | 56,933 | May 16, 2025 |
| Elazzouzi Amy | Senior Vice President, Finance | Sale | 897 | $5.49 | $4,925 | 81,381 | Apr 16, 2025 |
| Kilroy Conor | See Remarks | Sale | 7,162 | $5.49 | $39,319 | 179,313 | Apr 16, 2025 |
| Bitetti Teresa Marie | — | Award / Grant | 21,000 | — | — | 21,000 | Mar 31, 2025 |
| Plavsic Mark | Chief Technology Officer | Sale | 2,151 | $7.75 | $16,670 | 209,456 | Feb 18, 2025 |
| Elazzouzi Amy | Senior Vice President, Finance | Sale | 1,404 | $7.75 | $10,881 | 82,278 | Feb 18, 2025 |
| Hopkins Janet Jill | Chief Medical Officer | Sale | 2,534 | $7.75 | $19,639 | 269,794 | Feb 18, 2025 |
| de los Pinos Elisabet | See Remarks | Sale | 20,221 | $7.75 | $156,713 | 482,440 | Feb 18, 2025 |
| de los Pinos Elisabet | See Remarks | Award / Grant | 194,320 | — | — | 502,661 | Feb 3, 2025 |
| Plavsic Mark | Chief Technology Officer | Award / Grant | 90,475 | — | — | 211,607 | Feb 3, 2025 |
| Hopkins Janet Jill | Chief Medical Officer | Award / Grant | 120,635 | — | — | 272,328 | Feb 3, 2025 |
| Kilroy Conor | See Remarks | Award / Grant | 90,475 | — | — | 186,475 | Feb 3, 2025 |
| Elazzouzi Amy | Senior Vice President, Finance | Award / Grant | 45,240 | — | — | 83,682 | Feb 3, 2025 |
| de los Pinos Elisabet | See Remarks | Sale | 15,955 | $7.67 | $122,375 | 304,692 | Jan 21, 2025 |
| Elazzouzi Amy | Vice President, Finance | Sale | 1,001 | $7.67 | $7,678 | 38,442 | Jan 21, 2025 |
| Hopkins Janet Jill | Chief Medical Officer | Sale | 11,822 | $9.36 | $110,654 | 151,693 | Nov 18, 2024 |
| de los Pinos Elisabet | See Remarks | Sale | 9,200 | $10.74 | $98,808 | 320,647 | Oct 29, 2024 |
| Elazzouzi Amy | Vice President, Finance | Sale | 553 | $10.74 | $5,939 | 39,443 | Oct 29, 2024 |
| Feder Julie B | Chief Financial Officer | Option Exercise | 5,000 | $5.48 | $27,400 | 159,407 | Oct 18, 2024 |
| de los Pinos Elisabet | See Remarks | Sale | 24,992 | $12.04 | $300,904 | 329,847 | Oct 18, 2024 |
| Plavsic Mark | Chief Technology Officer | Sale | 7,383 | $9.85 | $72,723 | 121,132 | Oct 16, 2024 |
| de los Pinos Elisabet | See Remarks | Option Exercise | 5,474 | $5.76 | $31,530 | 329,847 | Sep 27, 2024 |
| Mattessich Antony C. | — | Award / Grant | 10,500 | — | — | 10,500 | Jun 20, 2024 |
| Srivastava Sapna | — | Award / Grant | 10,500 | — | — | 10,500 | Jun 20, 2024 |
| Johnson David Michael | — | Award / Grant | 10,500 | — | — | 146,167 | Jun 20, 2024 |
| Kilroy Conor | General Counsel and Secretary | Award / Grant | 96,000 | — | — | 96,000 | Apr 2, 2024 |
| Hopkins Janet Jill | Chief Medical Officer | Award / Grant | 28,515 | — | — | 163,515 | Feb 1, 2024 |
| Feder Julie B | Chief Financial Officer | Award / Grant | 71,285 | — | — | 134,276 | Feb 1, 2024 |
| de los Pinos Elisabet | See Remarks | Award / Grant | 162,935 | — | — | 324,373 | Feb 1, 2024 |
| de los Pinos Elisabet | See Remarks | Sale | 15,853 | $7.64 | $121,117 | 161,438 | Jan 23, 2024 |
| Feder Julie B | Chief Financial Officer | Sale | 6,609 | $7.64 | $50,493 | 62,991 | Jan 23, 2024 |
| Matrix Capital Management Company, LP | — | Purchase | 1,560,000 | $9.00 | $14,040,000 | 6,922,870 | Nov 9, 2023 |
| Johnson David Michael | — | Purchase | 76,000 | $7.17 | $544,920 | 126,066 | Nov 8, 2023 |
| de los Pinos Elisabet | See Remarks | Option Exercise | 3,800 | $2.74 | $10,412 | 184,740 | Nov 6, 2023 |
| Feder Julie B | Chief Financial Officer | Option Exercise | 3,900 | $2.74 | $10,686 | 73,500 | Nov 6, 2023 |
| Hopkins Janet Jill | Chief Medical Officer | Award / Grant | 135,000 | — | — | 135,000 | Nov 1, 2023 |
| Feder Julie B | Chief Financial Officer | Sale | 3,385 | $6.82 | $23,086 | 69,600 | Oct 30, 2023 |
| de los Pinos Elisabet | See Remarks | Sale | 9,586 | $6.83 | $65,472 | 180,940 | Oct 30, 2023 |
| Johnson David Michael | — | Purchase | 6,566 | $8.61 | $56,533 | 50,066 | Oct 3, 2023 |